Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. Foa R, Bassan R, Elia L, Piciocchi A, et al. J Clin Oncol 2024;42:881-885.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Foa R, Bassan R, Elia L, Piciocchi A, et al. Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. J Clin Oncol 2024;42:881-885.
PMID: 38127722